These results indicated that FK228 suppressed U87‐vIII cell tumour growth and induced cell cycle arrest in vivo and that EGFR‐vIII epigenetically silenced USP11, while FK228 partially released this inhibition. The gene discussed is EGFR; the disease is neoplasm.